IT201700101704A1 - Nuovo uso per trattamento delle infezioni da clostridium difficile - Google Patents

Nuovo uso per trattamento delle infezioni da clostridium difficile

Info

Publication number
IT201700101704A1
IT201700101704A1 IT102017000101704A IT201700101704A IT201700101704A1 IT 201700101704 A1 IT201700101704 A1 IT 201700101704A1 IT 102017000101704 A IT102017000101704 A IT 102017000101704A IT 201700101704 A IT201700101704 A IT 201700101704A IT 201700101704 A1 IT201700101704 A1 IT 201700101704A1
Authority
IT
Italy
Prior art keywords
treatment
new use
clostridium infections
difficult clostridium
difficult
Prior art date
Application number
IT102017000101704A
Other languages
English (en)
Inventor
Andrea Biffi
Original Assignee
Sofar Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sofar Spa filed Critical Sofar Spa
Priority to IT102017000101704A priority Critical patent/IT201700101704A1/it
Priority to CA3075235A priority patent/CA3075235A1/en
Priority to RU2020112241A priority patent/RU2020112241A/ru
Priority to AU2018333114A priority patent/AU2018333114A1/en
Priority to JP2020514676A priority patent/JP7387587B2/ja
Priority to BR112020004780-5A priority patent/BR112020004780A2/pt
Priority to DK18773856.2T priority patent/DK3681470T3/da
Priority to KR1020207010497A priority patent/KR20200065004A/ko
Priority to US16/642,337 priority patent/US11338002B2/en
Priority to PL18773856.2T priority patent/PL3681470T3/pl
Priority to MX2020002727A priority patent/MX2020002727A/es
Priority to CN201880059030.6A priority patent/CN111246839B/zh
Priority to ES18773856T priority patent/ES2969690T3/es
Priority to PCT/IB2018/056956 priority patent/WO2019053604A1/en
Priority to EP18773856.2A priority patent/EP3681470B1/en
Publication of IT201700101704A1 publication Critical patent/IT201700101704A1/it
Priority to JP2023193960A priority patent/JP2024003162A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicinal Preparation (AREA)
IT102017000101704A 2017-09-12 2017-09-12 Nuovo uso per trattamento delle infezioni da clostridium difficile IT201700101704A1 (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IT102017000101704A IT201700101704A1 (it) 2017-09-12 2017-09-12 Nuovo uso per trattamento delle infezioni da clostridium difficile
KR1020207010497A KR20200065004A (ko) 2017-09-12 2018-09-12 클로스트리듐 디피실리 감염을 치료하기 위한 새로운 용도
US16/642,337 US11338002B2 (en) 2017-09-12 2018-09-12 Use for treatment of clostridium difficile infections
AU2018333114A AU2018333114A1 (en) 2017-09-12 2018-09-12 New use for treatment of Clostridium difficile infections
JP2020514676A JP7387587B2 (ja) 2017-09-12 2018-09-12 クロストリジウム・ディフィシル感染症の治療における新たな使用
BR112020004780-5A BR112020004780A2 (pt) 2017-09-12 2018-09-12 uso para o tratamento de infecções por clostridium difficile
DK18773856.2T DK3681470T3 (da) 2017-09-12 2018-09-12 Lactobacillus casei eller lactobacillus paracasei til anvendelse i behandling af clostridium difficile-infektioner
CA3075235A CA3075235A1 (en) 2017-09-12 2018-09-12 New use for treatment of clostridium difficile infections
RU2020112241A RU2020112241A (ru) 2017-09-12 2018-09-12 Новые приемы для лечения инфекций clostridium difficile
PL18773856.2T PL3681470T3 (pl) 2017-09-12 2018-09-12 Lactobacillus casei lub lactobacillus paracasei do stosowania w leczeniu infekcji clostridium difficile
MX2020002727A MX2020002727A (es) 2017-09-12 2018-09-12 Nuevo uso para tratamiento de infecciones por clostridium difficile.
CN201880059030.6A CN111246839B (zh) 2017-09-12 2018-09-12 用于治疗艰难梭菌感染的新用途
ES18773856T ES2969690T3 (es) 2017-09-12 2018-09-12 Lactobacillus casei o Lactobacillus paracasei para su uso en el tratamiento de infecciones por Clostridium difficile
PCT/IB2018/056956 WO2019053604A1 (en) 2017-09-12 2018-09-12 NEW USE FOR THE TREATMENT OF DIFFICULT CLOSTRIDIUM INFECTIONS
EP18773856.2A EP3681470B1 (en) 2017-09-12 2018-09-12 Lactobacillus casei or lactobacillus paracasei for use in the treatment of clostridium difficile infections
JP2023193960A JP2024003162A (ja) 2017-09-12 2023-11-14 クロストリジウム・ディフィシル感染症の治療における新たな使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000101704A IT201700101704A1 (it) 2017-09-12 2017-09-12 Nuovo uso per trattamento delle infezioni da clostridium difficile

Publications (1)

Publication Number Publication Date
IT201700101704A1 true IT201700101704A1 (it) 2019-03-12

Family

ID=60991413

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000101704A IT201700101704A1 (it) 2017-09-12 2017-09-12 Nuovo uso per trattamento delle infezioni da clostridium difficile

Country Status (15)

Country Link
US (1) US11338002B2 (it)
EP (1) EP3681470B1 (it)
JP (2) JP7387587B2 (it)
KR (1) KR20200065004A (it)
CN (1) CN111246839B (it)
AU (1) AU2018333114A1 (it)
BR (1) BR112020004780A2 (it)
CA (1) CA3075235A1 (it)
DK (1) DK3681470T3 (it)
ES (1) ES2969690T3 (it)
IT (1) IT201700101704A1 (it)
MX (1) MX2020002727A (it)
PL (1) PL3681470T3 (it)
RU (1) RU2020112241A (it)
WO (1) WO2019053604A1 (it)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131467A1 (it) 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
MA39710A (fr) 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
MA45288A (fr) 2016-06-08 2019-04-17 Sofar Spa Nouvelle utilisation médicale de probiotiques
IT201600122724A1 (it) 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
JP7369709B2 (ja) * 2018-10-10 2023-10-26 ニュートリー株式会社 クロストリジウム・ディフィシル菌感染症の予防及び／又は治療剤
JP2022535875A (ja) * 2019-06-05 2022-08-10 ラック２バイオーム・ソチエタ・ア・レスポンサビリタ・リミタータ 細菌株ラクトバチルス・パラカゼイおよびヒアルロン酸を含む組成物および皮膚の治療のためのその使用
IT201900016865A1 (it) * 2019-09-20 2021-03-20 Sofar Spa Composizioni a base di ceppi batterici e loro uso come antinfiammatori
JP7362417B2 (ja) * 2019-10-25 2023-10-17 ライオン株式会社 口腔内病原性細菌の生育抑制剤、口腔用組成物及び促進剤
WO2021081362A1 (en) * 2019-10-25 2021-04-29 Newgen 27, Llc Synbiotic compositions for gut microbiota
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
CN112322553B (zh) * 2020-11-30 2022-09-27 四川大学华西医院 一种抗艰难梭菌的乳酸乳球菌及其应用
CN112442472B (zh) * 2020-11-30 2023-05-26 四川大学华西医院 抗艰难梭菌的重组乳酸乳球菌、活载体疫苗及其制备方法
CN112625983B (zh) * 2021-03-05 2021-05-28 山东中科嘉亿生物工程有限公司 一种对腹泻有治疗效果的干酪乳杆菌L.Casei21及其应用
WO2023287025A1 (ko) * 2021-07-12 2023-01-19 한국생명공학연구원 큐티박테리움 아비덤 균주, 그의 유래의 배양액 및 그의 항균 용도
KR102391832B1 (ko) * 2021-08-04 2022-04-28 한국식품연구원 클로스트리디오이데스 디피실 억제용 유산균 복합 균주 및 이를 포함하는 장염증 예방, 치료 또는 개선용 조성물
KR102452957B1 (ko) * 2022-03-14 2022-10-11 한동대학교 산학협력단 프로바이오틱스 균주를 유효성분으로 포함하는 클로스트리디오이데스 디피실레 감염을 예방 또는 치료하기 위한 조성물
KR102539773B1 (ko) * 2022-11-14 2023-06-07 주식회사 바이오뱅크힐링 루미노코커스 락타리스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102539776B1 (ko) * 2022-11-14 2023-06-07 주식회사 바이오뱅크힐링 홀데마넬라 바이포미스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102539772B1 (ko) * 2022-11-14 2023-06-07 주식회사 바이오뱅크힐링 락토코커스 락티스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
CN116004483B (zh) * 2023-03-09 2023-06-02 四川厌氧生物科技有限责任公司 一种预防或治疗腹泻的格氏乳球菌及其应用
KR102628941B1 (ko) * 2023-08-08 2024-01-26 주식회사 바이오뱅크힐링 프레보텔라 코프리 균주, 및 그의 유래의 소포체 및그의 항염증 및 항균 용도
KR102620185B1 (ko) * 2023-08-08 2024-01-04 주식회사 바이오뱅크힐링 블라우티아 호미니스 균주, 및 그의 유래의 소포체및 그의 항염증 및 항균 용도
KR102620188B1 (ko) * 2023-08-08 2024-01-04 주식회사 바이오뱅크힐링 락티카제이바실러스 지애 균주, 및 그의 유래의 소포체및 그의 항염증 및 항균 용도
KR102620187B1 (ko) * 2023-08-08 2024-01-04 주식회사 바이오뱅크힐링 리길락토바실러스 루미니스 균주, 및 그의 유래의 소포체및 그의 항염증 및 항균 용도

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005123100A1 (en) * 2004-06-18 2005-12-29 Bio-K Plus International Inc. Lactic bacteria and their use in the prevention of diarrhea

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
JP5905032B2 (ja) * 2011-02-09 2016-04-20 ラヴィヴォ・アーベー 腸管内微生物叢の回復および再構成のためのシンバイオティクス組成物
ITMI20131473A1 (it) * 2013-09-06 2015-03-07 Sofar Spa Metodo per valutare gli effetti di una composizione comprendente microrganismi sul microbiota intestinale
ITMI20131467A1 (it) * 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
MA39710A (fr) * 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005123100A1 (en) * 2004-06-18 2005-12-29 Bio-K Plus International Inc. Lactic bacteria and their use in the prevention of diarrhea

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EFSA PANEL ON DIETETIC PRODUCTS ET AL: "Scientific Opinion on the substantiation of health claims related to Lactobacillus casei DG CNCM I-1572 and decreasing potentially pathogenic gastro intestinal microorganisms (ID 2949, 3061, further assessment) pursuant to Article 13(1) of Regulation (EC)", THE EFSA JOURNAL, vol. 10, no. 6, 1 June 2012 (2012-06-01), Parma, IT, pages 2723, XP055339010, ISSN: 1831-4732, DOI: 10.2903/j.efsa.2012.2723 *
SILVIA BALZARETTI ET AL: "The vaginal isolate Lactobacillus paracasei LPC-S01 (DSM 26760) is suitable for oral administration", FRONTIERS IN MICROBIOLOGY, vol. 6, 15 September 2015 (2015-09-15), XP055474499, DOI: 10.3389/fmicb.2015.00952 *
XING WANG GAO ET AL: "Dose - Response Efficacy of a Proprietary Probiotic Formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile -Associated Diarrhea Prophylaxis in Adult Patients", AMERICAN JOURNAL OF GASTROENTEROLOGY, 9 February 2010 (2010-02-09), pages 1636 - 1641, XP055026421, Retrieved from the Internet <URL:http://www.nature.com/ajg/journal/v105/n7/pdf/ajg201011a.pdf> [retrieved on 20120508], DOI: 10.1038/ajg.2010.11 *

Also Published As

Publication number Publication date
BR112020004780A2 (pt) 2020-09-24
JP2020533351A (ja) 2020-11-19
WO2019053604A1 (en) 2019-03-21
AU2018333114A1 (en) 2020-04-09
EP3681470A1 (en) 2020-07-22
MX2020002727A (es) 2020-10-28
RU2020112241A3 (it) 2021-11-12
JP2024003162A (ja) 2024-01-11
DK3681470T3 (da) 2024-02-05
US11338002B2 (en) 2022-05-24
KR20200065004A (ko) 2020-06-08
EP3681470B1 (en) 2023-11-08
CA3075235A1 (en) 2019-03-21
CN111246839A (zh) 2020-06-05
PL3681470T3 (pl) 2024-04-02
RU2020112241A (ru) 2021-10-18
CN111246839B (zh) 2023-11-21
JP7387587B2 (ja) 2023-11-28
US20200306323A1 (en) 2020-10-01
ES2969690T3 (es) 2024-05-22

Similar Documents

Publication Publication Date Title
IT201700101704A1 (it) Nuovo uso per trattamento delle infezioni da clostridium difficile
DK3706796T3 (da) Eksosomerer som RNA terapeutikske midler
DK3785717T3 (da) Fremgangsmåder til behandling af coronaviridae-infektioner
DK3641819T3 (da) Anvendelse af cannabidiol i behandling af tuberøst sklerosekompleks
DK3600456T3 (da) Fremgangsmåde til sterilisering
DK3692857T3 (da) Indretning til levering af hudplejesammensætning
ES2796903T8 (es) Procedimiento de uso de inmunoconjugados anti-CD79b
CL2016002569A1 (es) Anticuerpos, composiciones farmacéuticas y usos de los mismos
DK3474802T3 (da) Medicinsk forbinding
DK3785733T3 (da) Farmaceutisk sammensætning til behandling af autisme
FR3016513B1 (fr) Station de travail medicale extra-hospitaliere
BR112017008125A2 (pt) redução da viscosidade de formulações farmacêuticas
DK3634377T3 (da) Farmaceutisk formulering
DK3373874T4 (da) Medicinsk forbinding
DK3265057T3 (da) Topisk formulering
FR3039396B1 (fr) Base de formulation cosmetique concentree
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
DK3218382T3 (da) 2,3-dihydro-thiazolo[3,2-a]pyridin-5-on derivativer som antibiotika til behandling af klamydiainfektioner
DK3601277T3 (da) Farmaceutisk formulering
DK3324736T3 (da) Hidtil ukendt spot-on-aktivstofformulering
DK3319586T3 (da) Farmaceutisk formulering til behandling af inflammatoriske forandringer i endetarmen
FR3032614B1 (fr) Composition cosmetique nettoyante
DK3417847T3 (da) Desinfektionsmiddelsammensætning til oftalmisk anvendelse
FI11688U1 (fi) Sukka potilaskäyttöä varten
DK3434147T3 (da) Stol